| P50 | author | Gokhan Duruksu | Q57339648 |
| | Gizem Turaç | Q85821269 |
| P2093 | author name string | Erdal Karaoz | |
| P2860 | cites work | Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 | Q25938983 |
| | Characterization of mesenchymal stem cells from rat bone marrow: ultrastructural properties, differentiation potential and immunophenotypic markers | Q28574524 |
| | A centrosomal localization signal in cyclin E required for Cdk2-independent S phase entry | Q28578943 |
| | The human tyrosine hydroxylase gene promoter | Q31137126 |
| | Direct intracerebral gene transfer of an adenoviral vector expressing tyrosine hydroxylase in a rat model of Parkinson's disease | Q64383353 |
| | Therapeutic effects of differentiated bone marrow stromal cell transplantation on rat models of Parkinson's disease | Q79148684 |
| | Increased Notch 1 expression and attenuated stimulatory G protein coupling to adenylyl cyclase in osteonectin-null osteoblasts | Q79545312 |
| | A high-efficiency induction of dopaminergic cells from human umbilical mesenchymal stem cells for the treatment of hemiparkinsonian rats | Q85698441 |
| | Marrow stromal cells form guiding strands in the injured spinal cord and promote recovery | Q34012747 |
| | Grafting fibroblasts genetically modified to produce L-dopa in a rat model of Parkinson disease | Q34320662 |
| | Potential of mesenchymal stem cells in gene therapy approaches for inherited and acquired diseases | Q34367266 |
| | N-cadherin-mediated cell adhesion restricts cell proliferation in the dorsal neural tube | Q34888155 |
| | Stem cell therapy for human neurodegenerative disorders-how to make it work | Q35844778 |
| | WNT signaling increases proliferation and impairs differentiation of stem cells in the developing cerebellum | Q35893623 |
| | Differentiation of Human Dental Pulp Stem Cells into Dopaminergic Neuron-like Cells in Vitro. | Q36509897 |
| | Cyclin D1 is a direct target of JAG1-mediated Notch signaling in breast cancer | Q38348851 |
| | Human dental pulp stem cells demonstrate better neural and epithelial stem cell properties than bone marrow-derived mesenchymal stem cells. | Q39712429 |
| | Bone marrow-derived mesenchymal stem cells co-cultured with pancreatic islets display β cell plasticity. | Q39747492 |
| | Transplantation of undifferentiated human mesenchymal stem cells protects against 6-hydroxydopamine neurotoxicity in the rat. | Q39776151 |
| | Efficacy of Tyrosine Hydroxylase gene modified neural stem cells derived from bone marrow on Parkinson's disease--a rat model study | Q39861102 |
| | The therapeutic effects of tyrosine hydroxylase gene transfected hematopoetic stem cells in a rat model of Parkinson's disease | Q40181263 |
| | Dopaminergic neural grafts after fifteen years: results and perspectives. | Q40576807 |
| | Cyclin E/Cdk2 activity is controlled by different mechanisms in the G0 and G1 phases of the cell cycle | Q41162309 |
| | Fetal nigral transplantation as a therapy for Parkinson's disease | Q41367101 |
| | Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain | Q42280576 |
| | In vivo release of dopa and dopamine from genetically engineered cells grafted to the denervated rat striatum | Q42831252 |
| | Long-term behavioral recovery in parkinsonian rats by an HSV vector expressing tyrosine hydroxylase | Q43185222 |
| | Intrastriatal grafts of mesenchymal stem cells in adult intact rats can elevate tyrosine hydroxylase expression and dopamine levels | Q43233627 |
| | Mesenchymal stem cell transplantation attenuates blood brain barrier damage and neuroinflammation and protects dopaminergic neurons against MPTP toxicity in the substantia nigra in a model of Parkinson's disease. | Q43264133 |
| | Therapeutic benefit of TH-engineered mesenchymal stem cells for Parkinson's disease | Q45883394 |
| | Neurogenic potential of human mesenchymal stem cells revisited: analysis by immunostaining, time-lapse video and microarray | Q46642929 |
| | Particle bombardment-mediated gene transfer and expression in rat brain tissues | Q48317110 |
| | CNTF+BDNF treatment and neuroprotective pathways in the rd1 mouse retina | Q48343461 |
| | Human bone marrow stem cells exhibit neural phenotypes and ameliorate neurological deficits after grafting into the ischemic brain of rats | Q48675224 |
| | Reduction of lesion in injured rat spinal cord and partial functional recovery of motility after bone marrow derived mesenchymal stem cell transplantation. | Q48710776 |
| P275 | copyright license | Creative Commons Attribution-NonCommercial 4.0 International | Q34179348 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | mesenchymal stem cell | Q1922379 |
| | neuroprotection | Q1981368 |
| P304 | page(s) | 42-53 | |
| P577 | publication date | 2018-03-28 | |
| P1433 | published in | Neurospine | Q73908754 |
| P1476 | title | The Effect of Recombinant Tyrosine Hydroxylase Expression on the Neurogenic Differentiation Potency of Mesenchymal Stem Cells | |
| P478 | volume | 15 | |